EPO and polycythemia: A significant rise in needless tests for diagnosis, such as EPO serum dose, molecular testing (JAK2V617 and exon 12), and bone marrow biopsies, may result from the isolated use of the suggested Hb/Hct levels as a description of polycythemia.